Lack of erectogenic activity of a novel selective melanocortin-4 receptor agonist in a clinical experimental model

J Clin Pharmacol. 2008 Oct;48(10):1237-41. doi: 10.1177/0091270008320925. Epub 2008 Jun 16.
No abstract available

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Cross-Over Studies
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Erectile Dysfunction / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Piperazines / pharmacology
  • Purines / pharmacology
  • Receptor, Melanocortin, Type 4 / antagonists & inhibitors*
  • Sildenafil Citrate
  • Sulfones / pharmacology
  • Vasodilator Agents / pharmacology

Substances

  • Piperazines
  • Purines
  • Receptor, Melanocortin, Type 4
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate